Drug induced liver injury historical perspective
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rachita Navara, M.D. [2]
Overview
Overview
Drug induced liver injury has been historically underreported.
Historical Perspective
Historical Perspective
Over the last fifty years, the United States Food and Drug Administration has withdrawn several drugs from the market for causing severe liver injury. Notably in 1997 to 1998, bromfenac and troglitazone were withdrawn from the market for causing severe hepatocellular injury. Drug induced liver injury remains the most frequent single cause of drug withdrawals from the market today.[1]
References
References
- ↑ United States Food and Drug Administration. Guidance for Industry. http://www.fda.gov/downloads/Drugs/…/Guidances/UCM174090.pdf Accessed on October 24, 2016
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH